Table 1
Global deaths and DALYs of smoking‑induced tracheal, bronchus, and lung cancer from 1990 to 2021.
| YEAR | BOTH | FEMALE | MALE |
|---|---|---|---|
| 1990 | |||
| Deaths (95% UI) | 737,925.68 (686,229.20–791,982.05) | 117,068.52 (105,907.20–128,707.03) | 620,857.17 (577,879.96–669,544.06) |
| DALYs (95% UI) | 19,356,963.13 (18,071,732.80–20,777,679.76) | 2,873,527.83 (2,617,006.43–3,137,842.37) | 16,483,435.30 (15,356,336.71–17,770,216.31) |
| ASMR/100,000 persons (95% UI) | 18.72 (17.37–20.12) | 5.55 (5.00–6.11) | 34.85 (32.37–37.57) |
| ASDR/100,000 persons (95% UI) | 471.15 (438.80–505.43) | 133.69 (121.53–145.86) | 854.09 (796.48–920.94) |
| 2021 | |||
| Deaths (95% UI) | 1,195,795.65 (1,054,669.94–1,359,222.56) | 220,125.05 (187,188.66–255,058.71) | 975,670.59 (843,775.90–1,123,054.48) |
| DALYs (95% UI) | 27,713,689.18 (24,404,593.21–31,596,581.23) | 4,780,176.62 (4,165,305.62–5,493,258.44) | 22,933,512.55 (19,793,991.37–26,526,587.66) |
| ASMR/100,000 persons (95% UI) | 13.85 (12.22–15.74) | 4.72 (4.02–5.47) | 24.68 (21.38–28.37) |
| ASDR/100,000 persons (95% UI) | 315.67 (278.19–359.86) | 103.13 (89.95–118.38) | 553.82 (479.27–639.64) |
| 1990‑2021 | |||
| PC of deaths (%) | 62.05 (39.75–85.51) | 88.03 (68.70–108.75) | 57.15 (31.66–83.99) |
| PC of DALYs (%) | 43.17 (23.41–64.74) | 66.35 (50.21–83.37) | 39.13 (15.84–63.97) |
| EAPC of ASMR (95% CI) | −0.97 (−1.05 to −0.89) | −0.59 (−0.75 to −0.43) | −1.10 (−1.16 to −1.03) |
| EAPC of ASDR (95% CI) | −1.29 (−1.37 to −1.22) | −0.86 (−1.02 to −0.70) | −1.39 (−1.45 to −1.33) |
[i] DALYs, disability‑adjusted life‑years; ASMR, age‑standardized mortality rate; ASDR, age‑standardized disability‑adjusted life‑year rate; PC, percentage change; EAPC, estimated annual percentage change; UI, uncertainty interval; CI, confidence interval.
Figure 1
EAPCs of the ASRs for smoking‑induced TBL cancer from 1990 to 2021. A. EAPCs of the ASMR for smoking‑induced TBL cancer in 21 regions and 5 SDI regions. B. EAPCs of the ASDR for smoking‑induced TBL cancer in 21 regions and 5 SDI regions. ASRs, age‑standardized rates; ASMR, age‑standardized mortality rate; ASDR, age‑standardized disability‑adjusted life‑year rate; EAPC, estimated annual percentage change; SDI, sociodemographic index; TBL cancer, tracheal, bronchus, and lung cancer.
Figure 2
Gender differences in ASRs for smoking‑induced TBL cancer in 2021. A. Gender differences in ASMR for smoking‑induced TBL cancer across 21 regions. B. Gender differences in ASDR for smoking‑induced TBL cancer across 21 regions. ASRs, age‑standardized rates; ASMR, age‑standardized mortality rate; ASDR, age‑standardized disability‑adjusted life‑year rate; TBL cancer, tracheal, bronchus, and lung cancer.
Figure 3
EAPCs of the ASRs for smoking‑induced TBL cancer from 1990 to 2021. A. EAPCs of the ASMR for smoking‑induced TBL cancer in 204 countries and regions. B. EAPCs of the ASDR for smoking‑induced TBL cancer in 204 countries and regions. ASRs, age‑standardized rates; ASMR, age‑standardized mortality rate; ASDR, age‑standardized disability‑adjusted life‑year rate; EAPC, estimated annual percentage change; TBL cancer, tracheal, bronchus, and lung cancer.
Figure 4
ASRs for smoking‑induced TBL cancer of 21 regions by SDI. A. ASMRs for smoking‑induced TBL cancer of 21 regions from 1990−2021 according to the SDI. B. ASDRs for smoking‑induced TBL cancer of 21 regions from 1990−2021 according to the SDI. ASRs, age‑standardized rates; ASMR, age‑standardized mortality rate; ASDR, age‑standardized disability‑adjusted life‑year rate; SDI, sociodemographic index; TBL cancer, tracheal, bronchus, and lung cancer.
Figure 5
ASRs for smoking‑induced TBL cancer of 204 countries and territories by SDI. A. ASMRs for smoking‑induced TBL cancer of 204 countries and territories in 2021 according to the SDI. B. ASDRs for smoking‑induced TBL cancer of 204 countries and territories in 2021 according to the SDI. ASRs, age‑standardized rates; ASMR, age‑standardized mortality rate; ASDR, age‑standardized disability‑adjusted life‑year rate; SDI, sociodemographic index; TBL cancer, tracheal, bronchus, and lung cancer.
Figure 6
EAPCs of the ASRs for smoking‑induced TBL cancer in 204 countries and territories by SDI. A. EAPCs of the ASMRs for smoking‑induced TBL cancer in 204 countries and territories by SDI in 2021. B. EAPCs of the ASDRs for smoking‑induced TBL cancer in 204 countries and territories by SDI in 2021. ASRs, age‑standardized rates; ASMR, age‑standardized mortality rate; ASDR, age‑standardized disability‑adjusted life‑year rate; EAPC, estimated annual percentage change; SDI, sociodemographic index; TBL cancer, tracheal, bronchus, and lung cancer.
Figure 7
Age‑specific numbers and rates of deaths and DALYs of smoking‑induced TBL cancer by gender in 2021. A. Age‑specific numbers and rates of deaths from smoking‑induced TBL cancer. B. Age‑specific numbers and rates of DALYs from smoking‑induced TBL cancer. DALYs, disability‑adjusted life‑years; TBL cancer, tracheal, bronchus, and lung cancer.